- Home
- LDP vs TCMD Comparison
LDP vs TCMD Comparison
Compare LDP & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LDP | TCMD |
|---|---|---|
| Founded | 2012 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 606.3M | 533.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | LDP | TCMD |
|---|---|---|
| Price | $20.70 | $24.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 66.2K | ★ 335.9K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | N/A | ★ 17.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.60 |
| Revenue Next Year | N/A | $9.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.35 | $9.42 |
| 52 Week High | $22.05 | $37.77 |
Technical Indicators
Market Signals| Indicator | LDP | TCMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.47 | 49.25 |
| Support Level | $20.60 | $22.78 |
| Resistance Level | $21.10 | $27.19 |
| Average True Range (ATR) | 0.23 | 1.01 |
| MACD | 0.01 | 0.18 |
| Stochastic Oscillator | 59.43 | 55.81 |
Price Performance
Historical ComparisonAbout LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.